Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Health for Life Capital fund

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 8
Average round size
info
The average size of a deal this fund participated in
$38M
Portfolio companies 5
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.38
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Biopharma
  • Drug Discovery
  • Life Science
  • Health Care
Summary

The typical case for the fund is to invest in rounds with 6-7 participants. Despite the Health for Life Capital fund, startups are often financed by Seventure Partners, Lundbeckfonden Ventures, Innovation Network Corporation of Japan. The meaningful sponsors for the fund in investment in the same round are Seventure Partners, Tao Capital Partners, Shinsei Corporate Investment Limited. In the next rounds fund is usually obtained by Tyson Ventures, Taiho Ventures, TMI Investments BV.

Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most successful fund investment fields, there are Biotechnology, Organic Food. Among the various public portfolio startups of the fund, we may underline Axial Biotherapeutics, MycoTechnology, ENTEROME Bioscience The fund has no exact preference in some founders of portfolio startups. In case when startup counts 3 or 5+ of the founder, the chance for it to get the investment is meager.

The important activity for fund was in 2017. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 investment rounds annually.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Health for Life Capital fund:
Typical Co-investors
Health for Life Capital fund is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Health for Life Capital fund:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Amador Holdings Ciudad De Panamá, Panamá, Panama
Arctos Capital California, San Francisco, United States
Cameleon Invest France, Ile-de-France, Paris
China Health Industry Investment Fund -
Cure Kids Ventures -
Ellis Accelerator New York, New York, United States
Eos Capital Khomas, Namibia, Windhoek
FullCycle California, Los Angeles, United States
Hangzhou Kang Sheng Health Management -
Hanwha Asset Management Seoul, Seoul-t'ukpyolsi, South Korea
Jinan Tongtai China, Jinan, Shandong
MiMo Capital Florida, Miami, United States
Qicheng Chuang Tou China, Dongguan, Hebei
Rongtong Capital Management China, Guangdong, Shenzhen
Russian Foundation for Technological Development -
SARORAS Private Capital New York, New York, United States
Sectoral Asset Management Canada, Montréal, Quebec
Xinganxian Media Investment China, Hangzhou, Zhejiang
Xingfen Yaotu China, Zhejiang, Zhoushan
Yifan Capital -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Axial Biotherapeutics

Biopharma
Biotechnology
Medical
Pharmaceutical
$25M27 Feb 2019 Massachusetts, United States

MycoTechnology

Advanced Materials
Agriculture
Biotechnology
Food and Beverage
Organic Food
$42M29 Aug 2017 Aurora, Colorado, United States

ENTEROME

Biopharma
Biotechnology
Drug Discovery
Health Care
Life Science
$17M20 Apr 2016 Ile-de-France
News
Vedanta Biosciences Raises $68M in Series D Financing

– Vedanta Biosciences, Inc. from Cambridge, MA develops new category of oral therapies using defined bacterial consortia manufactured from clonal cell banks.
– The company closed a $68m Series D financing.
– The round was led by affiliates of Magnetar Capital with participation from Verition Fund Management, Fosun Health Capital, co-founder PureTech Health (Nasdaq: PRTC, LSE: PRTC), Rock Springs Capital, Skyviews Life Science, JSR Corporation, SymBiosis LLC, Shumway Capital, Health for Life Capital (Seventure Partners), and other institutional investors.
– The company plans to use the funds to advance its pipeline of defined bacterial consortia, including progressing VE303 into a Phase 3 clinical trial in patients at high risk for recurrentCDI, initiating a Phase 2 clinical trial of VE202 in mild to moderate ulcerative colitis, and continuing to advance programs in additional indications.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Health for Life Capital fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 8
Average round size 38M
Peak activity year 2017
Lead investments 0
Follow on index 0.38
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Axial Biotherapeutics

Biopharma
Biotechnology
Medical
Pharmaceutical
$25M27 Feb 2019 Massachusetts, United States

MycoTechnology

Advanced Materials
Agriculture
Biotechnology
Food and Beverage
Organic Food
$42M29 Aug 2017 Aurora, Colorado, United States

ENTEROME

Biopharma
Biotechnology
Drug Discovery
Health Care
Life Science
$17M20 Apr 2016 Ile-de-France
Crunchbase icon

Content report

The following text will be sent to our editors: